Eads & Heald Wealth Management Purchases 547 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Eads & Heald Wealth Management increased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 20.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,175 shares of the medical research company’s stock after acquiring an additional 547 shares […]